| Recruitment status | Open public recruiting |
| Unique ID issued by UMIN | UMIN000033497 |
| Receipt No. | R000038199 |
| Official scientific title of the study | Study on pulmonary perfusion blood flow and prognosis of venous thromboembolism |
| Date of disclosure of the study information | 2018/07/25 |
| Last modified on | 2018/07/24 (Ver. 1) |
| Basic information | ||
| Official scientific title of the study | Study on pulmonary perfusion blood flow and prognosis of venous thromboembolism | |
| Title of the study (Brief title) | pulmonary perfusion blood flow | |
| Region |
|
|
| Condition | ||
| Condition | Venous thromboembolism | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | Venous thromboembolism is a disease that is occasionally lethal due to pulmonary embolism, and it is one of diseases with a high incidence in university hospitals dealing with many malignant diseases. IQon Spectral CT newly introduced at our hospital since January this year is a multi-slice CT equipped with a dual layer detector, and spectral imaging by this CT is based on incident X-rays obtained by spectroscopy of continuous X- Multiple energy and its accompanying substance interactions are utilized, and composite image analysis results and new substance information by conventional CT images and various spectral images can be obtained in all inspections. As a result, not only anatomical findings but also information on lung perfusion blood flow rate can be obtained for pulmonary embolism (D. Sueta, D. Utsunomiya et al.. Anticoagulation therapy has been established as the first choice for treatment of pulmonary embolism, but its efficacy evaluation has not been sufficiently elucidated. By evaluating lung perfusion blood flow before and after the treatment of patients who evaluated images in our venous thromboembolic event this time we can quantitatively evaluate their efficacy. |
| Basic objectives2 | Safety,Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | Confirmatory |
| Trial characteristics_2 | Explanatory |
| Developmental phase | Not applicable |
| Assessment | |
| Primary outcomes | We investigate lung perfusion blood flow before and after treatment. |
| Key secondary outcomes | |
| Base | |
| Study type | Observational |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | We will cover all patients with venous thromboembolism from January to March, Heisei era. | |||
| Key exclusion criteria | none | |||
| Target sample size | 500 | |||
| Research contact person | |
| Name of lead principal investigator | Daisuke Sueta |
| Organization | Kumamoto University Hospital |
| Division name | Cardiovascular Medicine |
| Address | 1-1-1 Honjo, Kumamoto |
| TEL | 096-373-5175 |
| sueta-d@kumamoto-u.ac.jp | |
| Public contact | |
| Name of contact person | Daisuke Sueta |
| Organization | Kumamoto University Hospital |
| Division name | Cardiovascular Medicine |
| Address | 1-1-1 Honjo, Kumamoto |
| TEL | 096-373-5175 |
| Homepage URL | |
| sueta-d@kumamoto-u.ac.jp | |
| Sponsor | |
| Institute | Kumamoto University Hospital |
| Institute | |
| Department | |
| Funding Source | |
| Organization | None |
| Organization | |
| Division | |
| Category of Funding Organization | Other |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | YES |
| Study ID_1 | Senshin 2243 |
| Org. issuing International ID_1 | Senshin 2243 |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Open public recruiting | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | None |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000038199 |